StockNews.com Begins Coverage on Senseonics (NYSE:SENS)

StockNews.com started coverage on shares of Senseonics (NYSE:SENS) in a report published on Friday. The firm issued a sell rating on the stock.

Separately, HC Wainwright reaffirmed a buy rating and issued a $2.00 target price on shares of Senseonics in a research note on Wednesday, August 14th.

Senseonics Trading Down 2.9 %

Senseonics stock opened at $0.40 on Friday. The company has a current ratio of 3.11, a quick ratio of 2.89 and a debt-to-equity ratio of 59.17. Senseonics has a 12 month low of $0.32 and a 12 month high of $0.75. The stock’s 50 day simple moving average is $0.41 and its two-hundred day simple moving average is $0.45. The firm has a market cap of $211.71 million, a PE ratio of -2.82 and a beta of 0.79.

Senseonics (NYSE:SENS) last announced its earnings results on Thursday, August 8th. The company reported ($0.03) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.03). Senseonics had a negative return on equity of 299.69% and a negative net margin of 335.15%. The firm had revenue of $4.87 million for the quarter, compared to analyst estimates of $4.86 million. Analysts anticipate that Senseonics will post -0.13 earnings per share for the current year.

Institutional Investors Weigh In On Senseonics

Several institutional investors have recently added to or reduced their stakes in the business. RPO LLC acquired a new position in Senseonics during the fourth quarter worth approximately $37,000. Mirae Asset Global Investments Co. Ltd. lifted its position in shares of Senseonics by 30.2% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 909,931 shares of the company’s stock valued at $483,000 after acquiring an additional 211,128 shares in the last quarter. State Board of Administration of Florida Retirement System acquired a new position in Senseonics in the first quarter valued at $91,000. Vanguard Group Inc. increased its stake in Senseonics by 0.7% during the first quarter. Vanguard Group Inc. now owns 22,525,039 shares of the company’s stock worth $11,963,000 after acquiring an additional 155,715 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its stake in Senseonics by 16.1% during the first quarter. Price T Rowe Associates Inc. MD now owns 367,200 shares of the company’s stock worth $196,000 after acquiring an additional 51,000 shares during the last quarter. Hedge funds and other institutional investors own 12.36% of the company’s stock.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.